聚β-D-(1,6) -N-乙-葡萄糖胺 (PNAG) 甘氨酸疫苗具有广泛的中和活性
Kuo-Shiang Liao1,2, Mu-Rong Kao1,2,3, Tzu-Hsuan Ma2,3
1Genomics Research Center, Academia Sinica, Taipei, Taiwan.
Nature communications
|July 4, 2025
概括
开发有效的细菌疫苗是一项挑战. 这项研究优化了多N-乙-D-葡萄糖胺 (PNAG) 候选疫苗,确定了增强抗体对诸如黄金葡萄球菌 (Staphylococcus aureus) 等病原体有效性的特定结构.
科学领域:
- 免疫学 免疫学 免疫学
- 疫苗开发 疫苗开发
- 碳水化合物化学 碳水化合物化学
背景情况:
- 由于抗原的多样性,细菌疫苗的开发面临着障碍.
- 聚-N-乙-D-葡萄糖胺 (PNAG) 是一种保存的表面多糖体抗原.
- 以前的基于PNAG的疫苗由于未知的最佳抗原特征而显示出有限的疗效.
研究的目的:
- 开发一种控制合成的策略,用于PNAG甘氨酸.
- 为了确定最佳的PNAG结构特征,以增强抗体反应.
- 为了评估优化的PNAG结合物作为疫苗候选物的疗效.
主要方法:
- 采用n+2糖化策略对部分和完全脱乙烯化PNAG (dPNAG) 甘进行受控合成.
- 利用糖甘微阵列分析来确定最佳的dPNAG链长度 (DP8和DP12).
- 与蛋白质结合的最佳dPNAG结构和评估的抗体标位,opsonic活性和小鼠的体内保护.
主要成果:
- 确定了dPNAG甘氨酸与DP8和DP12作为最佳的抗原结构.
- dPNAG的蛋白质结合物引起了高的IgG标位,DP8结合物 (40%乙化) 显示出对三种医院病原体的优越声活性.
- 在小鼠中,dPNAG DP8 合物对黄金葡萄球菌提供了显著的保护.
结论:
- 优化的PNAG结构,特别是dPNAG DP8与40%的乙化,代表了有希望的疫苗候选人.
- 这项研究为开发更有效的针对PNAG的疫苗提供了基础.
- 这些发现支持dPNAG合物在抗击细菌感染方面的潜力.
相关概念视频
01:26Biosynthesis of Polysaccharides
Polysaccharides such as glycogen and starch are synthesized from nucleoside diphosphate sugars, primarily uridine diphosphate glucose (UDPG) and adenosine diphosphate glucose (ADPG). These activated glucose donors act as key intermediates in carbohydrate metabolism and biosynthesis. UDPG primarily involves glycogen synthesis in animals and many bacteria, while ADPG plays a fundamental role in starch synthesis in plants and certain bacteria.UDPG is formed when glucose-1-phosphate reacts with...
01:28Peptidoglycan Synthesis
Structure of PeptidoglycanPeptidoglycan is a vital structural component of the bacterial cell wall, providing mechanical strength and shape to the cell. It consists of repeating units of two sugars—N-acetylglucosamine (NAG) and N-acetylmuramic acid (NAM)—linked by β-1,4 glycosidic bonds. These sugar chains are cross-linked by short peptide chains, forming a mesh-like polymer that surrounds the bacterial plasma membrane.Cytoplasmic Phase – Precursor SynthesisPeptidoglycan biosynthesis begins in...
01:22Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...